The Medicare Part D $2,100 Out-of-Pocket Cap Explained (2026)

For decades, Medicare Part D had no limit on how much a beneficiary could spend on prescription drugs in a single year. People taking expensive specialty medications for cancer, rheumatoid arthritis, or multiple sclerosis could face tens of thousands of dollars in annual drug costs with no ceiling in sight.

The Part D out-of-pocket cap is a true maximum for covered drug costs. In 2026, the cap is $2,100 (up from $2,000 in 2025). Once the amounts you pay at the pharmacy total $2,100 in a calendar year, your plan pays 100 percent of the cost of covered drugs for the remainder of that year. You pay nothing at the pharmacy for covered drugs after reaching the cap.

The cap applies to the deductible, copays, and coinsurance you pay for covered drugs. In 2026, the standard Part D deductible is $590. If your plan charges a deductible, that amount counts toward your $2,100 cap. Every copay and coinsurance payment you make at the pharmacy also counts.

The cap resets on January 1 each year. There is no carryover from one year to the next. If you reach $2,100 in October, you benefit from free covered drugs in November and December, but you start over at $0 on January 1.

One of the most beneficiary-friendly aspects of the new cap is how manufacturer discounts are counted. Drug manufacturers are required to provide discounts on brand-name drugs for Part D enrollees. Under the new rules, these manufacturer discounts count toward your $2,100 out-of-pocket cap in 2026, even though you do not pay them directly.

This means that if you take an expensive brand-name specialty drug, the manufacturer's discount on that drug accelerates how quickly you reach the $2,100 cap. For example, if a specialty drug costs $3,000 per month and you pay 25 percent coinsurance ($750) while the manufacturer pays a $900 discount, both the $750 you paid and the $900 manufacturer discount count toward your $2,100 cap.

This provision is particularly valuable for people taking expensive specialty medications for conditions like cancer, rheumatoid arthritis, multiple sclerosis, and psoriasis. Reviewing your 2026 Medicare Advantage or Part D plan changes each year during open enrollment ensures you are on the plan that best covers your specific drugs.

A new optional program called the Medicare Prescription Payment Plan (MPPP) allows you to spread your out-of-pocket drug costs across monthly payments throughout the year, rather than paying large amounts at the pharmacy early in the year.

Without the MPPP, someone who takes expensive specialty drugs might reach their $2,100 cap by February or March, having paid large amounts at the pharmacy in January and February. The MPPP allows you to smooth those costs into equal monthly payments spread across the year.

To use the MPPP, you must opt in through your Part D plan. Once enrolled, your plan pays the pharmacy on your behalf and then bills you monthly for your share of the costs, divided into equal payments. The total amount you pay over the year is the same, but the timing is spread out.

The MPPP is optional and may not be beneficial for everyone. It is most useful for people who take expensive brand-name or specialty drugs and would otherwise face large pharmacy bills early in the year.

The $2,100 cap in 2026 is most impactful for people who take expensive specialty medications. Before the cap was introduced in 2025, a person taking a specialty drug costing $5,000 per month could face annual out-of-pocket drug costs of $10,000 or more. With the cap, their maximum exposure is $2,100 per year.

People with cancer, rheumatoid arthritis, multiple sclerosis, psoriasis, and other conditions treated with high-cost specialty drugs benefit most from this change. For these individuals, the cap can represent savings of thousands of dollars per year.

People who take only low-cost generic medications may not notice much difference. However, the cap provides valuable protection if your drug needs change due to a new diagnosis or a change in treatment. Understanding your full Medicare costs for 2026 helps you budget for both premiums and pharmacy costs.

The Low Income Subsidy program, also called Extra Help, provides additional assistance with Part D costs for beneficiaries with limited income and resources. Extra Help pays some or all of the Part D premium, deductible, and copays.

In 2026, beneficiaries who receive full Extra Help pay no more than $4.50 for generic drugs and $11.20 for brand-name drugs, regardless of the drug's actual cost. The $2,100 cap applies on top of Extra Help, though beneficiaries receiving full Extra Help are unlikely to reach the cap given their low copays.

To qualify for Extra Help, your income must be below 150 percent of the federal poverty level and your resources must be below certain limits. You can apply through Social Security at ssa.gov or by calling 1-800-772-1213. A licensed Medicare advisor can also help you determine whether you qualify and assist with the application.